Search for Clinical Trial Results

Sponsored By

Lymphoma, Large-Cell, Anaplastic - 3 Studies Found

Status Study
Completed Study Name: Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)
Condition:
  • Hodgkin Disease
  • Lymphoma, Large-Cell, Anaplastic

Date: 2016-10-18
Interventions: Drug: Brentuximab Vedotin Brentuximab vedotin IV infusion.
Completed Study Name: Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
Condition: ALCL
Date: 2016-09-07
Interventions: Other: Blood sample
Active, not recruiting Study Name: A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
Condition:
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, NK-cell
  • Date: 2011-02-25
    Interventions:
    • Drug: brentuximab vedotin 1.2-